Springer, 2020. — 245 p. — ISBN: 978-981-15-2364-9
This book highlights recent advances in our understanding of sarcopenia and frailty in CKD. The prevalence of sarcopenia and frailty increases substantially as CKD progresses, and experimental studies have demonstrated the pivotal role of accumulated uremic toxin in the development of muscle wasting. Further, sarcopenia and frailty are associated with falls, bone fractures, cognitive impairment, and poor survival prognoses, especially in elderly CKD patients. The syndromes are also related to the risk of end-stage kidney disease.This book provides readers with a deeper understanding of the prevention and management of sarcopenia and frailty in CKD patients to improve their renal and overall health, and suggests directions for future basic and clinical research.
Epidemiology of Sarcopenia and Frailty in CKD
Molecular Mechanism of Muscle Wasting in CKD
Protein Energy Wasting in Chronic Kidney Disease
Benefit and Risk of Exercise Training in Chronic Kidney Disease Patients
Frailty in Patients with Pre-dialysis Chronic Kidney Disease: Toward Successful Aging of the Elderly Patients Transitioning to Dialysis in Japan
Exercise Interventions in Dialysis Patients
Exercise Intervention for Kidney Transplant Recipients: Recent Progress and Remaining Issues
Role of Nutrition and Rehabilitation in the Prevention and Management of Sarcopenia and Frailty
Nutritional Interventions in Elderly Pre-dialysis Patients
Nutritional Interventions in Dialysis Patients
Pharmacological Intervention for Sarcopenia in Chronic Kidney Disease
Oral Health Management for the Prevention of Sarcopenia and Frailty
Frailty and Cognitive Impairment in Chronic Kidney Disease
Polypharmacy and Frailty in Chronic Kidney Disease
Anemia Management and QOL and Frailty in CKD